
In a phase 2 trial, tofacitinib met its safety end point and lowered interferon and cytokine scores in adolescents and adults with Down syndrome.
Children with autism spectrum disorder are at risk of wandering or elopement. Asking parents some key questions about how their child’s communication skills and how the child acts in public areas can help keep the child safe. Here are 14 questions that can help keep these children safe.






